Nanotechnologies are often presented as breakthrough innovations, where technology transfer and knowledge-bridging will play a pivotal role in the industrial dynamics. This article investigates the model of knowledge transfer in the nanotechnologies in depth, by comparing it with the models of two recently emerged technologies: biotech and microelectronics. Our results show that the nanotechnology transfer model is very different from that involved in biotechnology evolution: while small-medium firms play a valuable technology-bringing role, the central function of "translating" new knowledge between public research and industry in carried by the larger firms, just as it was in the early stages of the microelectronics sector.
Introduction
It seems likely that the nanotechnology will be a significant factor in the 21 st century. The U.S. National Nanotechnology Initiative (NNI) has defined nanotechnology as "encompassing the science, engineering, and technology related to the understanding and control of matter at the length scale of approximately one to 100 nanometers". Nanotechnologies include the research and development of materials, devices, and systems that have novel properties and functions due to their nanoscale structures or components (Chen and Roco 2009 ).They offer the potential for ground-breaking scientific research, and hold out the promise both of increasing efficiency in traditional industries, and of fostering radically new applications in emerging technologies. Nanotechnologies are expected to have a huge positive impact on economic growth and to create new markets, which is why most industrialized countries and companies have invested billions of dollars in nanotech developments, and are expecting great returns.
Nanotechnologies are technologically multidisciplinary as well as have cross-industrial utility (Linton and Walsh 2004) : product and process applications have been and are being developed in areas ranging from medicine, electronics, optics, telecommunications, aerospace to energy (Niosi 2007) . Nanotechnology is seen as a breakthrough innovation, with technology transfer and knowledge-bridging playing a pivotal role in its birth and growth (Rothaermel and Thursby 2007) . This article investigates the model of technology transfer in the nanotech sector in depth in order to guide decision-makers in making the right choices for its further developments. To do so, we compare the case of the evolution of nanotech with those of two other recently emerged technologies -biotechnology and microelectronics: each of which has held out the innovative prospect of producing existing products using a completely different set of technical competencies (Walsh and Kirchhoff 2002) . Linton and Walsh (2004) describe them as "materials based technologies with concurrent product and process innovation curves and regard them as the likely engines of future economic growth".
Nanotechnologies are often compared to biotechnologies, due to the breakthroughs the latter have generated in the pharmaceutical industry (Zucker et al., 2007) . The integration of nanotechnologies could threaten the leadership of established firms in the same way, rendering their accumulated expertise redundant (Hill et al., 2003) , and creating emerging opportunities for new firms (Shea, 2005) . Such new entrants are better placed to take advantage of disruptive technologies than are incumbents, who may suffer from organizational inertia and short-term incentives, and face the prospect of having to cannibalize their own markets. If the comparison (with biotechnologies) holds, small-medium firms (SMEs) are likely to play a key role in the industrial dynamics of nanotechnologies, leading to industrial architectures mainly composed of dedicated spin-offs focused on bringing nanotechnology processes, tools and first generation materials, devices and systems to market (Chachamidou and al. 2008 ).
But nanotechnologies can also be compared to microelectronics, although here the comparison seems to point to a different industrial landscape. As Abernathy and Utterback (1978) Are the knowledge transfer models of nanotechnology, biotechnology and microelectronics similar?
Comparing nanotechnology with biotechnology
Many scholars (Rothaermel and Thursby 2007; Zucker and Darby 2007; Niosi 2007; Youties et al. 2008) have found that nanotechnology and biotechnology have exhibited similar technological evolutionary patterns. The pattern of biotechnology development has largely been based on the creation of research-intensive SMEs (Orsenigo, 1989 (Orsenigo, , 2001 Gambardella, 1995; Sharp 1985 , Kenney, 1986 , usually university spin-offs formed through the collaboration of a scientist and a professional manager, backed by venture capital, with the aim of applying new scientific discoveries to commercial product development (Mangematin et al. 2003) . In many cases these spin-offs benefited from access to top world experts (usually university scientists) on specific topics, and the firms" expertise has essentially been in research areas directly related to the scientific field of their expert"s original laboratory. The product of such firms has exclusively almost been research within a relatively narrow range, and -in terms of their ability to translate their research into innovations -these small-medium firms have typically lacked critical assets in manufacturing, testing and marketing areas, access to regulatory agencies and to distribution channels in the pharmaceutical and food industries. In order to integrate such biotechnology innovation capabilities, SMEs have had to develop different forms of collaboration with established firms. It has been argued that since large pharmaceutical companies were committed to the old organic chemistry paradigm, where all their competences were concentrated, they could not easily internalize the new biotechnological knowledge; and that few of them had the absorptive capacity required to internalize the new paradigm or could construct such a capacity rapidly (Pyka and Saviotti, 2005) . So these collaborative arrangements between small and large firms provided both partners with access to the competences and assets they lacked: large companies to the SMEs" scientific discoveries -and the potential of receiving royalties if they had commercial potential -and SMEs to commercial markets. Consequently, the biotechnology industry is characterized by a network structure of inter-organizational alliances among the different actors involved: research institutions and large and small-medium firms, in which the latter are seen as a nexus, mediating between the scientists and the large established commercial players (Mangematin et al. 2003 ).
In such frameworks, the SMEs play a key role in the process of co-producing and translating knowledge, acting essentially as intermediaries bridging the gap between public research institutions and large chemical and pharmaceutical companies, buying research outputs from their discoverers, developing or refining them towards specific objectives, and then selling this knowledge on to larger partners for downstream commercialization (Greis et al., 1995; Zucker and Darby, 1997) . Orsenigo (1989) argues that this specialization of biotech start-ups "… provided an institutional solution to the transfer problem" and Orsenigo et al. (2001) refer to these new organizations as "specialized technology originators", while Pyka and Saviotti (2005) refer to their role as "translators". The biotech technology transfer model thus has SMEs as central economic actors. Zucker and Darby (2007) show that the evolution of nanotechnology is following the same pattern: firms are entering where and when academics scientists publish breakthrough articles.
They suggest that the production of nanotechnological knowledge is embedded in the wider social context of cross-institutional collaboration, and expect development patterns to be based on strong ties between academe and industry leading to the creation of spin-offs. In their framework, the process of knowledge transfer from science and engineering to industrial application involves academic (Zucker and Darby 2007 
Comparing nanotechnology with microelectronics
Abernathy and Utterback (1978), Peck (1986) and Braun and MacDonald (1978) have stressed the fundamental role that large firms played in the early stages of the microelectronics industry. Peck (1986) and Levin (1982) point out that there was no profound interaction between scientific theory and technological practice during the first years of the development of the transistor: the integrated circuit concept did not rest on any novel application of scientific theory: rather it was an engineering achievement. In the same vein, Mowery (1983) argues that the evolution of the industry structure is best explained by reference to the central role of manufacturing processes: "the pure science input into semiconductor innovation currently is rather modest; it is production engineering that is critical." Arcangeli et al. (1991) highlighted that the accumulation of knowledge in the early stage of microelectronics industry was mainly based on the history, technical knowledge and forms of corporate organization inherited from electromechanical technologies. Braun and MacDonald (1978) explained that, in the first two decades of the computer and semiconductor industries, large integrated producers (such as AT&T and IBM) designed their own solid-state components, manufactured the majority of the capital equipment used in their production process and utilized internally produced components in the manufacture of electronic computers and computer software that was leased or sold to their customers.
However Levin (1982) points out that, by the late 1970s, technical progress increasingly required more research than had characterized industry"s early stage, while Peck (1986) notes that three entities were already positioned with large programs to carry out such research:
IBM, AT&T and the large Japanese computer and semiconductor firms, and that large-scale R&D projects carried out jointly by profit-making corporations became increasingly important in the computer and semiconductor industries. These efforts -largely organized and funded by governments -generally focused on longer term generic research, leaving product and process development to smaller individual companies, thus making up for the small scale their research capabilities. In that framework, a few large firms played the fundamental roles in the process of knowledge co-production, based on partnerships created in the early stage of the microelectronics industry. Thus internal R&D and large-scale research projects which involved both large companies and public research seems to have been the principal vector of the co-production and transfer of knowledge, positioning the large firms as the central economic actors. A recent paper by argues that, in nanotechnology development, large firms hybridize their existing knowledge base with these newly emerging technologies, and shows how they are investing in pre-adaptation so as to speed up the development of new technologies and to be ready as markets emerge. This pattern suggests that the nanotech technology transfer model is closer to that of microelectronics, with large firms having the fundamental role, and contention which we examine in this paper by testing a second proposition:
Proposition # 2: Do large firms play a fundamental role in co-producing and transferring knowledge in nanotechnology by acting as a node of high centrality directly linking the industry's co-patenting network with public research in nanotechnology.

Data and Methodology
Data acquisition
To explore these two propositions, we built a database of firms involved in nanotechnologies, to develop a data set of nanotechnology-related patents from 1998-2006, which were collected from the PATSTAT EPO database (which collects data coming from 73 offices worldwide).
We identified 617,000 nanotechnology applications from the more than 65,000,000 patents listed PATSTAT in our focal period, and used a keyword-based approach to select a subset of the patents related to nanotechnologies (Mogoutov et al. 2007 ). We ended up with 9,447 companies that had patented in nanotechnologies.
We matched this database with ORBIS to discover economic and financial information about our data set firms. ORBIS is a comprehensive world-wide database of information on 60 million companies, combining information from nearly 100 sources filtered into various standard report formats. This search found 3,719 firms involved in nanotechnology (which we label "nanotech firms"). ORBIS define four categories of firms: (VL) Very Large companies (operating revenue of at least US$40m or over 1000 employees), (L) Large companies (operating revenue at least US$14m or over 150 employees), (M) Medium sized companies (operating revenue at least US$ 1.4 million or over 15 employees and (S) Small companies (those not included in another category). Using this classification, we identified 2,140 (58%) of our nanotech firms as being large or very large firms, and 1,579 (42%) as being small or medium firms (SMEs).
Tables 1, 2, 3 and 4 describe the main characteristics of our population of 3,719 nanotech firms. 1 We observe that 71% of nanotech SMEs were created after 1990. Since the potential of understanding the nanoscale properties of matter and the formulation of key research opportunities were becoming clearer by 2000 (Roco, Williams and Alivisatos, 2000) -we can suppose that these firms were created to apply these new scientific discoveries to commercial product development. In contrast, 70% of large-very nanotech large firms were created before 1990: we can characterize these firms as investing in nanotechnology, but being not dedicated nanotech companies. 100.00 Table 2 shows that about 90% of nanotech SMEs are located in Europe and US/Canada (while large-very large nanotech firms are mostly located in Europe (48%) and US Canada (24%) but also in Asia (21%). have shown that the investment of Asian firms in nanotechnology is mainly centered on nanoelectronics, a sector that remains dominated by large companies. Table 3 shows that 42% of nanotech SMEs have high nano patenting intensity (more than 50%), but 60% of the large nanotech firms have nano patenting intensities of less than 10%. 
Network construction
The network concept is a relatively new methodology that is used in many disciplinesincluding economics, sociology and organizational theory -to analyze different interaction structures among actors. Developed within the framework of graph theory, it is increasingly used to study industry networks composed of different but interrelated groups of actors (e.g., firms, suppliers, customers, universities, and other institutions). To capture the role of SMEs in the process of nanotech knowledge co-production, we introduce network concepts and measures to represent the relations between such different actors as universities, nonprofit institutions, governmental institutions, hospitals and companies, focusing on technological collaboration expressed through co-patenting. Niosi (2007) reminds us that patents are key to protecting intellectual propriety in both the biotechnology and nanotechnology arenas and, despite the objection that patents are by definition static and may thus represent incomplete criteria with which to measure knowledge flows, we argue that co-patent networks offer a valuable way of examining R&D collaboration structures (Goetze C., 2010) -Degree: is the simplest topological index, corresponding to the number of nodes adjacent (i.e., directly connected) to a given node (also called its "first neighbors") ;
-Average degree: is the average number of links a node has with other nodes;
-Average Clustering coefficient: is the average of all the nodes" clustering coefficients.
A single node"s clustering coefficient is the ratio of the number of links between the node"s neighbors (the nodes directly connected to it) to the number of possible links between them. The co-patent network"s average coefficient thus indicates the tendency for analytical units to form "local" clusters, with denser local clusters indicating nodes that are more likely to be influenced by their neighbors.
Secondly, since we are focusing on centrality, which concerns the roles of individuals (in our case, firms) in a network, we measure several related factors (such as degree, closeness, betweenness and eccentricity).
-Degree: is the number of direct links a particular node has;
-Eccentricity: of a node is calculated by computing the shortest path between it and all other nodes on the graph;
-Closeness: The closeness of a node is calculated by computing the shortest paths between it all the other nodes in the graph and summing these values. Closeness should be always compared to eccentricity: a node with high eccentricity + high closeness is very likely to be central on the graph (and thus to the network);
-Betweenness: provides an elaborated and informative centrality index, and counts the number of shortest paths linking a node couple (v1, v2) and passing through another node n.
From these topological measures and centrality parameters, we can identify the co-patent network's global structure and infer the role of firms in the nanotechnology knowledge transfer model.
Findings and discussion 1 Small-medium firms do not operate as intermediaries between science and industry in nanotechnologies
The nanotechnology co-patent institution network is shown in Figure 1 and the main topological parameters in Table 1 The topological measures of the network (Table 1) show that the institutional co-patenting network only contains one connected component. At least one path exists between every pair of nodes in the institution"s co-patenting network -in other words, every type of actor directly or indirectly affects actors of other types through nanotechnology co-patenting activities.
Based on the analysis of this network, we observe that:
-Firms in the large-very large category appear to co-patent mainly with universities and nonprofit institutions and to a lesser extent with SMEs and governments.
-The SME category co-patents with all other actors, but most closely with LVL firms.
Thus, Proposition 1 is not supported: nanotech SMEs do not play a key role in bridging the gap between public research institutes and large companies, and so cannot be considered as the central initial economic actors in nanotech networks. Figure 2 visualizes the co-patenting network activity among our 3,719 firms. The network density is very low and there are 2,865 isolated nodes and, in activity terms, only 854 firms (23%) co-patent with other firms. The network"s topological measures (Table 2) show that the network contains 3,001 connected components, and the average number of neighbors is less than 1. To gain finer-grained information, we focused our analysis on the core of the network (Figure   3 ), which yielded a testbed of 533 firms, 1,315 co-patent relations, and 533 self-patent relations. The topological measures of the main firm co-patenting network (Table 3) shows that at least one path exists between every pair of nodes -in other word every firm in this core area of the network directly or indirectly affects another through co-patenting in nanotechnology R&D. Analyzing this network, we can observe that large-very large firms are more closely related to other firms, whereas small-medium firms are more peripheral, and this is confirmed by the centrality parameters shown in Table 4 . Based on firms with the top 40 highest eccentricity indices, we can observe that only 8 of these (highlighted in the table) are SMEs, while the other 32 firms are all large or very large firms. This implies that all firms in the co-patenting network are in proximity with large-very large firms, suggesting that they play a more important role in nanotechnology"s knowledge transfer model than do small-medium firms.
Large firms are central in the nanotechnology firm co-patenting network
Figure 2 Firm's co-patent network
These 32 large-very large firms have also high betweenness indices, suggesting they may act as gatekeepers and/or connectors in nanotechnology networks. We can therefore say that large-very large firms seem to play a central role in the process of co-production of knowledge, so, in contrast with proposition 1, proposition 2 seems to be confirmed. 
Conclusions
Our results show first that the model of technology transfer is very different from that of biotechnology. Contrary to what happened in the development of the biotech sector, small and medium nanotech firms play an important technology-bringing role, but do not play the key role as translator of new knowledge between public research and industry. We know that small firms provide specific equipment and research services to very large companies: indeed, working at the nanotech level requires specific equipment, simulation models, first generation materials, devices and software. The nanotech-value chain is supported by a set of tools including scanning probe microscopes, nanofabrication tools, and computer modeling systems. Following Rosenberg"s (1992) argument that scientific instruments can enable technologies that fuel subsequent down-stream discoveries, specific equipment, simulation models and specialized software play a similar role in nanotechnology R&D, and these are elements that are typically developed and commercialized by small firms. Government investment in the biotech sector was mainly channeled through supporting the creation of start-ups: but while this was quite successful in boosting technology transfer and the commercialization of R&D in that context, public policies designed to support nanotechnologies needs to be designed differently.
Our results reveal, secondly, that nanotechnology is being developed within large firms, along the same pattern seen in the early phases of microelectronics, since nanotech development requires the kind of large and diversifies knowledge bases that exist in large firms. At the current stage of nanotechnology evolution, the process of exploration and knowledge translation are based mainly on collaboration patterns inherited from earlier forms of industrial organization. In microelectronics, government was both the principal organizer and a major source of funding of large-scale research project -and in the same way, over $3bn of government money world-wide has been pumped into the development of nanotechnologies during the last couple of years, even though they are still in the early stage of their technological life cycles. However, they promise exciting long-term pay-offs to those governments that do invest.
